ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

Smokers’ Quitlines Work, California Study Finds

October 25, 2002

ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients

April 27, 2012

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014